Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2368431rdf:typepubmed:Citationlld:pubmed
pubmed-article:2368431lifeskim:mentionsumls-concept:C0024299lld:lifeskim
pubmed-article:2368431lifeskim:mentionsumls-concept:C0017526lld:lifeskim
pubmed-article:2368431lifeskim:mentionsumls-concept:C0205696lld:lifeskim
pubmed-article:2368431lifeskim:mentionsumls-concept:C1441616lld:lifeskim
pubmed-article:2368431pubmed:issue3lld:pubmed
pubmed-article:2368431pubmed:dateCreated1990-8-16lld:pubmed
pubmed-article:2368431pubmed:abstractTextThirty-one cases of thyroid malignancies which were originally classified as anaplastic carcinoma were reexamined immunohistochemically using PAP methods (peroxidase:antiperoxidase) for IgM, IgG, IgA, cytokeratin, calcitonin, lysozyme and alpha-1-antitrypsin. The reclassification results were compared with patient data such as clinical symptoms, treatment modalities, and clinical outcome. Postoperative radiotherapy was carried out in more than 80% of cases, chemotherapy in none. Seven of 31 tumors showed a positive staining for IgM (n = 4), IgG (n = 2), and IgA (n = 1) antibodies. All of these cases were negative for epithelial markers. Surprisingly, not only all small cell tumors (n = 3) but also 4 tissues with predominantly giant cell areas were among those reclassified as primary malignant lymphoma.lld:pubmed
pubmed-article:2368431pubmed:languageenglld:pubmed
pubmed-article:2368431pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2368431pubmed:citationSubsetIMlld:pubmed
pubmed-article:2368431pubmed:statusMEDLINElld:pubmed
pubmed-article:2368431pubmed:issn0364-2313lld:pubmed
pubmed-article:2368431pubmed:authorpubmed-author:HerfarthCClld:pubmed
pubmed-article:2368431pubmed:authorpubmed-author:TschaharganeC...lld:pubmed
pubmed-article:2368431pubmed:authorpubmed-author:BuhlBBlld:pubmed
pubmed-article:2368431pubmed:authorpubmed-author:MöllerPPlld:pubmed
pubmed-article:2368431pubmed:authorpubmed-author:MeybierHHlld:pubmed
pubmed-article:2368431pubmed:authorpubmed-author:HöltingTTlld:pubmed
pubmed-article:2368431pubmed:issnTypePrintlld:pubmed
pubmed-article:2368431pubmed:volume14lld:pubmed
pubmed-article:2368431pubmed:ownerNLMlld:pubmed
pubmed-article:2368431pubmed:authorsCompleteYlld:pubmed
pubmed-article:2368431pubmed:pagination291-4; discussion 295lld:pubmed
pubmed-article:2368431pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2368431pubmed:meshHeadingpubmed-meshheading:2368431-...lld:pubmed
pubmed-article:2368431pubmed:meshHeadingpubmed-meshheading:2368431-...lld:pubmed
pubmed-article:2368431pubmed:meshHeadingpubmed-meshheading:2368431-...lld:pubmed
pubmed-article:2368431pubmed:meshHeadingpubmed-meshheading:2368431-...lld:pubmed
pubmed-article:2368431pubmed:meshHeadingpubmed-meshheading:2368431-...lld:pubmed
pubmed-article:2368431pubmed:meshHeadingpubmed-meshheading:2368431-...lld:pubmed
pubmed-article:2368431pubmed:meshHeadingpubmed-meshheading:2368431-...lld:pubmed
pubmed-article:2368431pubmed:meshHeadingpubmed-meshheading:2368431-...lld:pubmed
pubmed-article:2368431pubmed:articleTitleImmunohistochemical reclassification of anaplastic carcinoma reveals small and giant cell lymphoma.lld:pubmed
pubmed-article:2368431pubmed:affiliationDepartment of Surgery, University of Heidelberg, Federal Republic of Germany.lld:pubmed
pubmed-article:2368431pubmed:publicationTypeJournal Articlelld:pubmed